GRM1 antibody

Ref. 3D-70R-15013

Produktinformation

• Name: GRM1 antibody

Beschreibung

The GRM1 antibody is a monoclonal antibody that has been developed for the treatment of thrombotic microangiopathy and atypical hemolytic disorders. It specifically targets the glucose transporter nuclear protein, which plays a crucial role in the development and progression of these conditions. The GRM1 antibody has shown promising results in preclinical studies, effectively reducing thrombotic events and improving overall patient outcomes. This drug antibody can be administered as an intravenous infusion, with the effective dose determined based on individual patient characteristics. In addition to its therapeutic potential, the GRM1 antibody is also widely used in life sciences research for various applications, including immunohistochemistry and flow cytometry analysis. Whether you are a researcher or a healthcare professional, the GRM1 antibody offers a valuable tool for studying and treating thrombotic microangiopathy and atypical hemolytic disorders.

• Marke: Biosynth